New HIV-focused drug gets approval by European regulator
GSK Plc said that its HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets had received a recommendation for marketing authorisation from the European Medicines Agency's human medicines committee. Cabotegravir,…
